Topoisomerase I inhibitors: camptothecins and beyond
- PMID: 16990856
- DOI: 10.1038/nrc1977
Topoisomerase I inhibitors: camptothecins and beyond
Abstract
Nuclear DNA topoisomerase I (TOP1) is an essential human enzyme. It is the only known target of the alkaloid camptothecin, from which the potent anticancer agents irinotecan and topotecan are derived. As camptothecins bind at the interface of the TOP1-DNA complex, they represent a paradigm for interfacial inhibitors that reversibly trap macromolecular complexes. Several camptothecin and non-camptothecin derivatives are being developed to further increase anti-tumour activity and reduce side effects. The mechanisms and molecular determinants of tumour response to TOP1 inhibitors are reviewed, and rational combinations of TOP1 inhibitors with other drugs are considered based on current knowledge of repair and checkpoint pathways that are associated with TOP1-mediated DNA damage.
Similar articles
-
Camptothecins and topoisomerase I: a foot in the door. Targeting the genome beyond topoisomerase I with camptothecins and novel anticancer drugs: importance of DNA replication, repair and cell cycle checkpoints.Curr Med Chem Anticancer Agents. 2004 Sep;4(5):429-34. doi: 10.2174/1568011043352777. Curr Med Chem Anticancer Agents. 2004. PMID: 15379698 Review.
-
An overview of topoisomerase I-targeting agents.Semin Hematol. 1998 Jul;35(3 Suppl 4):3-12. Semin Hematol. 1998. PMID: 9779876 Review.
-
Topoisomerase degradation, DSB repair, p53 and IAPs in cancer cell resistance to camptothecin-like topoisomerase I inhibitors.Biochim Biophys Acta. 2013 Jan;1835(1):11-27. doi: 10.1016/j.bbcan.2012.09.002. Epub 2012 Sep 21. Biochim Biophys Acta. 2013. PMID: 23006513 Review.
-
[Molecular determinants of response to topoisomerase I inhibitors].Bull Cancer. 2011 Nov;98(11):1287-98. doi: 10.1684/bdc.2011.1474. Bull Cancer. 2011. PMID: 22049384 Review. French.
-
Mechanisms of resistance to topoisomerase I-targeting drugs.Oncogene. 2003 Oct 20;22(47):7296-304. doi: 10.1038/sj.onc.1206935. Oncogene. 2003. PMID: 14576839 Review.
Cited by
-
Dibenzo[c,h][1,5]naphthyridinediones as topoisomerase I inhibitors: design, synthesis, and biological evaluation.J Org Chem. 2012 Jun 1;77(11):5167-72. doi: 10.1021/jo3006039. Epub 2012 May 15. J Org Chem. 2012. PMID: 22587603 Free PMC article.
-
Quantitative model of R-loop forming structures reveals a novel level of RNA-DNA interactome complexity.Nucleic Acids Res. 2012 Jan;40(2):e16. doi: 10.1093/nar/gkr1075. Epub 2011 Nov 25. Nucleic Acids Res. 2012. PMID: 22121227 Free PMC article.
-
DNA-protein crosslink repair.Nat Rev Mol Cell Biol. 2015 Aug;16(8):455-60. doi: 10.1038/nrm4015. Epub 2015 Jul 1. Nat Rev Mol Cell Biol. 2015. PMID: 26130008 Review.
-
Brc1 links replication stress response and centromere function.Cell Cycle. 2013 Jun 1;12(11):1665-71. doi: 10.4161/cc.24900. Epub 2013 May 8. Cell Cycle. 2013. PMID: 23656778 Free PMC article. Review.
-
Interfacial inhibitors.Bioorg Med Chem Lett. 2015 Sep 15;25(18):3961-5. doi: 10.1016/j.bmcl.2015.07.032. Epub 2015 Jul 18. Bioorg Med Chem Lett. 2015. PMID: 26235949 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials